AI-delivered DBT skills to prevent suicide in older adults with HIV

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Investigators will adapt Dialectical Behavior Therapy (DBT) skills into brief videos and an AI-powered conversational agent called Angel to address suicidal ideation in older adults living with HIV. The intervention is delivered via participants' smartphones and pairs skills training with on-demand chatbot coaching. A pilot of 50 participants aged 50 and older with evidence of suicide risk (but not imminently suicidal) will measure feasibility, usability, acceptability, and preliminary effects on self-efficacy to manage negative emotions. Findings will inform refinement and larger trials focused on suicide prevention in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 50+
* evidence of suicide risk as defined by at least one of the following: PHQ-9 suicide item \> 0, Ask Suicide Questions (ASQ, an NIMH-supported suicide risk screener with a version tailored for primary care) \> 0, expression of suicidal thoughts to the provider during appointment, a suicide attempt in the past year, or PHQ-9 total score ≥ 8,
* ability to read and communicate fluently in English or Spanish
* not at imminent risk for suicide (does not have significant intent to die within 48 hours)
* has a smartphone capable of texting and accessing the internet.

Exclusion Criteria:

* deemed clinically inappropriate to participate because of severe psychosis, severe substance use, or severe cognitive deficits that would interfere with their comprehending study and intervention material.

Where it's running

• New Jersey Community Research Initiative
  Newark, New Jersey, United States Recruiting
• RWJB Infectious Disease
  Newark, New Jersey, United States Not yet recruiting

Study contacts

• Principal investigator: Elissa Kozlov, PhD — Rutgers
• Study coordinator: Jared Khan, MPH
• Email: khanjj@sph.rutgers.edu
• Phone: 2016672414

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk

  This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.

  Recruiting Asan Medical Center · Seoul · NCT07857291

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.